IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding IO Biotech, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 19 | 18 | −1 |
| Shares | 14.9M | 15.5M | +594.7K (+4.0%) |
| Value | $76.9M | $72.2M | −$4.70M (−6.1%) |
New holders (5)
Institutions that held IO Biotech, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 75,000 | $350.0K | 0.01% |
| Citadel Advisors LLC | 14,426 | $67.0K | 0.00% |
| Cannell Capital LLC | 2,192 | $10.0K | 0.00% |
| UBS Group AG | 2,234 | $10.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 524 | $2.00K | 0.00% |
Sold out (6)
Institutions that held IO Biotech, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Vanguard Group Inc | 62,234 | $330.0K |
| Susquehanna International Group, LLP | 26,676 | $141.0K |
| Norges Bank | 25,000 | $132.5K |
| Jane Street Group, LLC | 14,280 | $76.0K |
| Ergoteles LLC | 11,126 | $59.0K |
| Stifel Financial Corp | 10,000 | $53.0K |